10-Q Filing

Oruka Therapeutics, Inc. CIK: 907654 Q1 2013

Filing Information

Form Type	10-Q
Accession Number	`0001564590-13-000015`
Period End Date	20130331
Filing Date	20130513
Fiscal Year	2013
Fiscal Period	Q1
XBRL Instance	abio-20130331.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 55 Income Statement 48 Cash Flow Statement 92 Stockholders Equity 62

Balance Sheet 55 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	3.19M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$3.54M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	2.66M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.92M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$5.94M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$4.23M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$456.00K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	3.19M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	2.66M	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$125.00K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$3.04M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$3.99M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$22.00K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$23.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$124.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$144.00K	USD	Point-in-time
Total assets	`Assets`	$3.21M	USD	Point-in-time
Total assets	`Assets`	$4.14M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$65.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$377.00K	USD	Point-in-time
Accrued compensation and employee benefits	`EmployeeRelatedLiabilitiesCurrent`	$60.00K	USD	Point-in-time
Accrued compensation and employee benefits	`EmployeeRelatedLiabilitiesCurrent`	$103.00K	USD	Point-in-time
Accrued expenses and other liabilities	`OtherLiabilitiesCurrent`	$383.00K	USD	Point-in-time
Accrued expenses and other liabilities	`OtherLiabilitiesCurrent`	$121.00K	USD	Point-in-time
Deferred rent, current portion	`DeferredRentCreditCurrent`	$8.00K	USD	Point-in-time
Deferred rent, current portion	`DeferredRentCreditCurrent`	$16.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$828.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$305.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$828.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$305.00K	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.001 par value; 100 million shares authorized at March 31, 2013 and December 31, 2012; 3,185,562 and 2,660,315 shares issued and outstanding at March 31, 2013 and December 31, 2012, respectively.	`CommonStockValue`	$3.00K	USD	Point-in-time
Common stock, $0.001 par value; 100 million shares authorized at March 31, 2013 and December 31, 2012; 3,185,562 and 2,660,315 shares issued and outstanding at March 31, 2013 and December 31, 2012, respectively.	`CommonStockValue`	$3.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$72.37M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$70.90M	USD	Point-in-time
Deficit accumulated during the development stage	`RetainedEarningsAccumulatedDeficit`	$-69.06M	USD	Point-in-time
Deficit accumulated during the development stage	`RetainedEarningsAccumulatedDeficit`	$-67.99M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$-678.00K	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$2.91M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$7.41M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$3.31M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$-19.69M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$-38.18M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$5.73M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$-619.00K	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$-115.00K	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$-5.74M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$6.77M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$4.14M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$3.21M	USD	Point-in-time

Income Statement 48 line items

Line Item	Tag	Value	Unit	Period
Research and development	`ResearchAndDevelopmentExpense`	$181.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$42.86M	USD	45 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$422.00K	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$43.47M	USD	45 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$889.00K	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$984.00K	USD	1 Quarter
Merger transaction costs	`BusinessCombinationAcquisitionRelatedCosts`	$5.47M	USD	45 Qtrs
Restructuring expense, net	`RestructuringCharges`	$2.41M	USD	45 Qtrs
Loss on impairment of in-process research and development	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	$6.00M	USD	45 Qtrs
Total costs and expenses	`OperatingExpenses`	$1.07M	USD	1 Quarter
Total costs and expenses	`OperatingExpenses`	$100.21M	USD	45 Qtrs
Total costs and expenses	`OperatingExpenses`	$1.41M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-100.21M	USD	45 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-1.41M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-1.07M	USD	1 Quarter
Gain on assignment of patent rights	`GainLossOnAssignmentOfPatentRights`	$2.00M	USD	45 Qtrs
Gain on bargain purchase	`BusinessCombinationBargainPurchaseGainRecognizedAmount`	$25.28M	USD	45 Qtrs
Gain on bargain purchase	`BusinessCombinationBargainPurchaseGainRecognizedAmount`	$25.30M	USD	Point-in-time
Interest and other income	`InterestAndOtherIncome`	$2.03M	USD	45 Qtrs
Interest and other expense	`InterestExpenseDebt`	$443.00K	USD	45 Qtrs
Interest and other expense	`InterestExpenseDebt`	$1.00K	USD	1 Quarter
Interest and other expense	`InterestExpenseDebt`	$1.00K	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-1.41M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-1.07M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-71.35M	USD	45 Qtrs
Benefit from income taxes	`IncomeTaxExpenseBenefit`	$-2.28M	USD	45 Qtrs
Net loss and comprehensive loss	`NetIncomeLoss`	$-4.32M	USD	Annual
Net loss and comprehensive loss	`NetIncomeLoss`	$-1.07M	USD	1 Quarter
Net loss and comprehensive loss	`NetIncomeLoss`	$-5.36M	USD	Annual
Net loss and comprehensive loss	`NetIncomeLoss`	$-5.24M	USD	Annual
Net loss and comprehensive loss	`NetIncomeLoss`	$-8.42M	USD	Annual
Net loss and comprehensive loss	`NetIncomeLoss`	$-9.14M	USD	Annual
Net loss and comprehensive loss	`NetIncomeLoss`	$-13.99M	USD	Annual
Net loss and comprehensive loss	`NetIncomeLoss`	$-69.06M	USD	45 Qtrs
Net loss and comprehensive loss	`NetIncomeLoss`	$-1.46M	USD	Annual
Net loss and comprehensive loss	`NetIncomeLoss`	$-1.41M	USD	1 Quarter
Net loss and comprehensive loss	`NetIncomeLoss`	$-116.00K	USD	8 Qtrs
Net loss and comprehensive loss	`NetIncomeLoss`	$-19.43M	USD	Annual
Net loss and comprehensive loss	`NetIncomeLoss`	$-511.00K	USD	Annual
Less: Accretion of redeemable convertible preferred stock	`PreferredStockAccretionOfRedemptionDiscount`	$245.00K	USD	45 Qtrs
Less: Deemed preferred stock dividend for additional common shares issuable under anti-dilution provisions	`PreferredStockDividendsAndOtherAdjustments`	$781.00K	USD	45 Qtrs
Net loss attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-70.09M	USD	45 Qtrs
Net loss attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-1.41M	USD	1 Quarter
Net loss attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-1.07M	USD	1 Quarter
Basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.69	USD	1 Quarter
Basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.35	USD	1 Quarter
Basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	3.03M	shares	1 Quarter
Basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	2.03M	shares	1 Quarter

Cash Flow Statement 92 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-4.32M	USD	Annual
Net loss	`NetIncomeLoss`	$-1.07M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-5.36M	USD	Annual
Net loss	`NetIncomeLoss`	$-5.24M	USD	Annual
Net loss	`NetIncomeLoss`	$-8.42M	USD	Annual
Net loss	`NetIncomeLoss`	$-9.14M	USD	Annual
Net loss	`NetIncomeLoss`	$-13.99M	USD	Annual
Net loss	`NetIncomeLoss`	$-69.06M	USD	45 Qtrs
Net loss	`NetIncomeLoss`	$-1.46M	USD	Annual
Net loss	`NetIncomeLoss`	$-1.41M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-116.00K	USD	8 Qtrs
Net loss	`NetIncomeLoss`	$-19.43M	USD	Annual
Net loss	`NetIncomeLoss`	$-511.00K	USD	Annual
Gain on patent rights assignment	`GainLossOnAssignmentOfPatentRights`	$2.00M	USD	45 Qtrs
Gain on bargain purchase	`BusinessCombinationBargainPurchaseGainRecognizedAmount`	$25.28M	USD	45 Qtrs
Gain on bargain purchase	`BusinessCombinationBargainPurchaseGainRecognizedAmount`	$25.30M	USD	Point-in-time
Depreciation and amortization	`DepreciationAndAmortization`	$10.00K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$1.79M	USD	45 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$14.00K	USD	1 Quarter
Non-cash interest expense	`PaidInKindInterest`	$211.00K	USD	45 Qtrs
Share-based compensation	`ShareBasedCompensation`	$42.00K	USD	1 Quarter
Share-based compensation	`ShareBasedCompensation`	$2.63M	USD	45 Qtrs
Share-based compensation	`ShareBasedCompensation`	$91.00K	USD	1 Quarter
Issuance of warrants for lease termination	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$377.00K	USD	45 Qtrs
Accretion of liabilities	`AccretionExpense`	$152.00K	USD	45 Qtrs
Impairment of property and equipment	`ImpairmentOfLongLivedAssetsHeldForUse`	$125.00K	USD	45 Qtrs
Loss on impairment of in-process research and development	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	$6.00M	USD	45 Qtrs
Write-off of deferred tax liability	`WriteOffOfDeferredTaxLiability`	$2.28M	USD	45 Qtrs
Gain on marketable securities available for sale	`MarketableSecuritiesGainLoss`	$263.00K	USD	45 Qtrs
(Gain) loss from disposal of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$-83.00K	USD	45 Qtrs
Other, net	`OtherNoncashIncomeExpense`	$-267.00K	USD	45 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$157.00K	USD	1 Quarter
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$-2.66M	USD	45 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$72.00K	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-7.35M	USD	45 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-20.00K	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-20.00K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$312.00K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-1.81M	USD	45 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-134.00K	USD	1 Quarter
Accrued expenses and other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-160.00K	USD	1 Quarter
Accrued expenses and other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$88.00K	USD	1 Quarter
Accrued expenses and other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-19.13M	USD	45 Qtrs
Deferred rent	`IncreaseDecreaseInDeferredCharges`	$8.00K	USD	45 Qtrs
Deferred rent	`IncreaseDecreaseInDeferredCharges`	$-8.00K	USD	1 Quarter
Deferred rent	`IncreaseDecreaseInDeferredCharges`	$-8.00K	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-1.66M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-764.00K	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-98.19M	USD	45 Qtrs
Cash received from Merger	`CashAcquiredFromAcquisition`	$30.39M	USD	45 Qtrs
Payment of deferred transaction costs	`OtherPaymentsToAcquireBusinesses`	$1.19M	USD	45 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$9.00K	USD	1 Quarter
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.89M	USD	45 Qtrs
Proceeds from sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$15.37M	USD	45 Qtrs
Proceeds from sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$358.00K	USD	45 Qtrs
Proceeds from patent rights assignment	`ProceedsFromSaleOfIntangibleAssets`	$2.00M	USD	45 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-9.00K	USD	1 Quarter
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$45.05M	USD	45 Qtrs
Proceeds from issuance of convertible notes payable and related warrants for common stock	`ProceedsFromIssuanceOrSaleOfEquity`	$10.84M	USD	45 Qtrs
Proceeds from issuance of bank note payable	`ProceedsFromNotesPayable`	$4.00M	USD	45 Qtrs
Proceeds from stock subject to repurchase	`ProceedsFromIssuanceOfRedeemablePreferredStock`	$38.00K	USD	45 Qtrs
Proceeds from the issuance of preferred stock	`ProceedsFromIssuanceOfPreferredStockAndPreferenceStock`	$32.32M	USD	45 Qtrs
Payment of offering costs	`PaymentsOfStockIssuanceCosts`	$60.00K	USD	1 Quarter
Payment of offering costs	`PaymentsOfStockIssuanceCosts`	$60.00K	USD	45 Qtrs
Proceeds from the issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$1.74M	USD	1 Quarter
Proceeds from the issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$15.85M	USD	45 Qtrs
Repayment of principal on bank note payable	`RepaymentsOfNotesPayable`	$4.00M	USD	45 Qtrs
Repayment of principal on convertible notes payables	`RepaymentsOfConvertibleDebt`	$105.00K	USD	45 Qtrs
Repayment of principal on vendor finance agreement	`RepaymentOfPrincipalOnVendorFinanceAgreement`	$43.00K	USD	1 Quarter
Repayment of principal on vendor finance agreement	`RepaymentOfPrincipalOnVendorFinanceAgreement`	$323.00K	USD	45 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$56.68M	USD	45 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-60.00K	USD	1 Quarter
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.39M	USD	1 Quarter
Net (decrease) increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$617.00K	USD	1 Quarter
Net (decrease) increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-1.72M	USD	1 Quarter
Net (decrease) increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$3.54M	USD	45 Qtrs
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$3.54M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$2.92M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$5.94M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$4.23M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$3.54M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$2.92M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$5.94M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$4.23M	USD	Point-in-time
Interest paid	`InterestPaid`	$1.00K	USD	1 Quarter
Interest paid	`InterestPaid`	$116.00K	USD	45 Qtrs
Accrued interest on notes payable converted to equity	`AccruedInterestOnNotesPayableConvertedToEquity`	$163.00K	USD	45 Qtrs
Warrant issued in connection with credit facility	`WarrantIssuedInConnectionWithCreditFacility`	$111.00K	USD	45 Qtrs
Accrued deferred transaction costs	`AccruedDeferredTransactionCosts`	$482.00K	USD	45 Qtrs
Vendor finance agreement	`VendorFinanceAgreement`	$131.00K	USD	1 Quarter
Vendor finance agreement	`VendorFinanceAgreement`	$134.00K	USD	1 Quarter
Vendor finance agreement	`VendorFinanceAgreement`	$131.00K	USD	45 Qtrs

Stockholders Equity 62 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance, value	`StockholdersEquity`	$-678.00K	USD	Point-in-time
Beginning Balance, value	`StockholdersEquity`	$2.91M	USD	Point-in-time
Beginning Balance, value	`StockholdersEquity`	$7.41M	USD	Point-in-time
Beginning Balance, value	`StockholdersEquity`	$3.31M	USD	Point-in-time
Beginning Balance, value	`StockholdersEquity`	$-19.69M	USD	Point-in-time
Beginning Balance, value	`StockholdersEquity`	$-38.18M	USD	Point-in-time
Beginning Balance, value	`StockholdersEquity`	$5.73M	USD	Point-in-time
Beginning Balance, value	`StockholdersEquity`	$-619.00K	USD	Point-in-time
Beginning Balance, value	`StockholdersEquity`	$-115.00K	USD	Point-in-time
Beginning Balance, value	`StockholdersEquity`	$-5.74M	USD	Point-in-time
Beginning Balance, value	`StockholdersEquity`	$6.77M	USD	Point-in-time
Issuance of stock for cash, net of offering costs, value	`StockIssuedDuringPeriodValueNewIssues`	$1.42M	USD	1 Quarter
Issuance of stock for cash, net of offering costs, value	`StockIssuedDuringPeriodValueNewIssues`	$1.00K	USD	Annual
Issuance of stock for cash, net of offering costs, value	`StockIssuedDuringPeriodValueNewIssues`	$1.00K	USD	8 Qtrs
Issuance of stock for cash, net of offering costs, value	`StockIssuedDuringPeriodValueNewIssues`	$7.00K	USD	Annual
Net loss	`NetIncomeLoss`	$-4.32M	USD	Annual
Net loss	`NetIncomeLoss`	$-1.07M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-5.36M	USD	Annual
Net loss	`NetIncomeLoss`	$-5.24M	USD	Annual
Net loss	`NetIncomeLoss`	$-8.42M	USD	Annual
Net loss	`NetIncomeLoss`	$-9.14M	USD	Annual
Net loss	`NetIncomeLoss`	$-13.99M	USD	Annual
Net loss	`NetIncomeLoss`	$-69.06M	USD	45 Qtrs
Net loss	`NetIncomeLoss`	$-1.46M	USD	Annual
Net loss	`NetIncomeLoss`	$-1.41M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-116.00K	USD	8 Qtrs
Net loss	`NetIncomeLoss`	$-19.43M	USD	Annual
Net loss	`NetIncomeLoss`	$-511.00K	USD	Annual
Ending Balance, value	`StockholdersEquity`	$-678.00K	USD	Point-in-time
Ending Balance, value	`StockholdersEquity`	$2.91M	USD	Point-in-time
Ending Balance, value	`StockholdersEquity`	$7.41M	USD	Point-in-time
Ending Balance, value	`StockholdersEquity`	$3.31M	USD	Point-in-time
Ending Balance, value	`StockholdersEquity`	$-19.69M	USD	Point-in-time
Ending Balance, value	`StockholdersEquity`	$-38.18M	USD	Point-in-time
Ending Balance, value	`StockholdersEquity`	$5.73M	USD	Point-in-time
Ending Balance, value	`StockholdersEquity`	$-619.00K	USD	Point-in-time
Ending Balance, value	`StockholdersEquity`	$-115.00K	USD	Point-in-time
Ending Balance, value	`StockholdersEquity`	$-5.74M	USD	Point-in-time
Ending Balance, value	`StockholdersEquity`	$6.77M	USD	Point-in-time
Issuance of common stock upon exercise of stock options, for cash, value	`StockIssuedDuringPeriodValueStockOptionsExercised`	$54.00K	USD	Annual
Issuance of common stock upon exercise of stock options, for cash, value	`StockIssuedDuringPeriodValueStockOptionsExercised`	$3.00K	USD	Annual
Issuance of common stock upon exercise of stock options, for cash, value	`StockIssuedDuringPeriodValueStockOptionsExercised`	$16.00K	USD	Annual
Issuance of common stock upon exercise of stock options, for cash, value	`StockIssuedDuringPeriodValueStockOptionsExercised`	$139.00K	USD	Annual
Issuance of common stock upon exercise of stock options, for cash, value	`StockIssuedDuringPeriodValueStockOptionsExercised`	$114.00K	USD	Annual
Issuance of common stock upon exercise of stock options, for cash, shares	`StockIssuedDuringPeriodSharesStockOptionsExercised`	-	shares	1 Quarter
Offering costs	`AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts`	$-17.00K	USD	Annual
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$308.00K	USD	Annual
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$42.00K	USD	1 Quarter
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$845.00K	USD	Annual
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$306.00K	USD	Annual
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$545.00K	USD	Annual
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$39.00K	USD	Annual
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$50.00K	USD	Annual
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$458.00K	USD	Annual
Estimated fair value of warrants issued in connection with convertible notes payable	`AdjustmentsToAdditionalPaidInCapitalWarrantIssued`	$399.00K	USD	Annual
Deemed preferred stock dividend for additional common shares issuable under anti-dilution provision	`DividendsPreferredStockStock`	$781.00K	USD	Annual
Restricted stock release from restriction	`AdjustmentToAdditionalPaidInCapitalRestrictedStockReleaseFromRestriction`	$75.00K	USD	Annual
Conversion of warrants for preferred stock	`AdjustmentToAdditionalPaidInCapitalConversionOfWarrantsForPreferredStock`	$36.00K	USD	Annual
Merger with Nuvelo, Inc., value	`StockIssuedDuringPeriodValueAcquisitions`	$11.91M	USD	Annual
Issuance of common stock under employee stock purchase plan and upon vesting of restricted stock units, value	`StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan`	$2.00K	USD	Annual
Estimated fair value of warrants issued in connection with lease termination	`AdjustmentToAdditionalPaidInCapitalEstimatedFairValueOfWarrantsIssued`	$377.00K	USD	Annual
Issuance of common stock upon exercise of warrants for cash, value	`StockIssuedDuringPeriodValueWarrantsExercised`	$12.00K	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.